ArticleMolecular and clinical oncology2023

Successful tepotinib treatment of adenocarcinoma with MET exon 14 skipping and discordant results between Oncomine Dx target test and ArcherMET: A case report.

Yoko Onodera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.